Geneva Capital Management LLC Avid Bioservices, Inc. Transaction History

Geneva Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.4 - $14.04 $576,210 - $860,637	-61,299 Reduced 2.64%	2,258,671 $21.3 Million
Q2 2023 Aug 01, 2023	SELL	$12.96 - $20.93 $76,969 - $124,303	-5,939 Reduced 0.26%	2,319,970 $32.4 Million
Q1 2023 May 12, 2023	BUY	$13.48 - $18.79 $6.59 Million - $9.19 Million	489,128 Added 26.63%	2,325,909 $43.6 Million
Q4 2022 Feb 07, 2023	BUY	$12.61 - $18.74 $5 Million - $7.43 Million	396,417 Added 27.52%	1,836,781 $25.3 Million
Q3 2022 Nov 02, 2022	BUY	$15.33 - $20.36 $22.1 Million - $29.3 Million	1,440,364 New	1,440,364 $27.5 Million
Q2 2022 Aug 02, 2022	SELL	$11.63 - $21.55 $288,889 - $535,302	-24,840 Reduced 1.79%	1,366,350 $20.9 Million
Q1 2022 May 02, 2022	BUY	$16.63 - $27.73 $23.1 Million - $38.6 Million	1,391,190 New	1,391,190 $28.3 Million

184

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $770M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Capital Management LLC with notifications on news.